Anavex Life Sciences Corp. (AVXL)
NASDAQ·Healthcare·Biotechnology
$3.21
+8.31%
Mkt Cap $254.85M
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
Implied Upside
+242.8%
Consensus $11.00 vs current $3.21
NASDAQ·Healthcare·Biotechnology
$3.21
+8.31%
Mkt Cap $254.85M
Buy
5
Hold
0
Sell
0
Price Target (1 analysts)
$11.00
Range $11.00 – $11.00
+242.8%
Consensus $11.00 vs current $3.21